Genentech Inc. is a major biopharmaceutical company. It lobbies Congress on drug-related issues, including Medicare and Medicaid coverage and reimbursement, the 340B drug discount program, and Medicare reimbursement for biosimilars. It also lobbies on tax rules affecting research and international taxation, and on intellectual property and trade issues such as patents and the TRIPS waiver.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
CALEB GRAFF
The latest disclosures for this client.
GENENTECH, INC
Q4GENENTECH, INC
Q3The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
These contribution items line up to this client through the same lobbying firm and reporting window, and when available the same contributing lobbyist.
GENENTECH, INC
DAN NEVES
GENENTECH, INC
ELISE MARIE CONNER
GENENTECH, INC
ESTEVAN SANTANA
GENENTECH, INC
JESSICA FRIEND
GENENTECH, INC
JILL SHOTZBERGER
GENENTECH, INC
MATTHEW L SULKALA
GENENTECH, INC
mr DAVID COOLING
GENENTECH, INC
GENENTECH, INC
Q2GENENTECH, INC
Q1